| Frailty prevalence and related factors in the older adult—FrailTURK Project S Eyigor, YG Kutsal, E Duran, B Huner, N Paker, B Durmus, N Sahin, ... Age 37, 1-13, 2015 | 143 | 2015 |
| Turkish Society of Physical Medicine and Rehabilitation, Geriatric Rehabilitation Working Group S Eyigor, YG Kutsal, E Duran, B Huner, N Paker, B Durmus, N Sahin, ... Frailty prevalence and related factors in the older adult-FrailTURK Project …, 2015 | 30 | 2015 |
| Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience E Bilgin, F Ceylan, E Duran, B Farisoğullari, EÇ Bölek, GK Yardimci, ... Turkish Journal of Medical Sciences 51 (1), 297-308, 2021 | 14 | 2021 |
| Is interferential current effective in the management of pain, range of motion, and edema following total knee arthroplasty surgery? A randomized double-blind controlled trial MR Kadı, S Hepgüler, FC Atamaz, E Duran, S Aydoğdu, K Aktuglu, ... Clinical rehabilitation 33 (6), 1027-1034, 2019 | 14 | 2019 |
| Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study A Di Matteo, E Cipolletta, GM Destro Castaniti, G Smerilli, C Airoldi, ... Rheumatology 61 (12), 4863-4874, 2022 | 11 | 2022 |
| Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: single centre, cross-disciplinary experience E Duran, T Yıldırım, A Taghiyeva, E Bilgin, M Arıcı, EA Sağlam, S Özen, ... Lupus 31 (9), 1147-1156, 2022 | 8 | 2022 |
| Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study E Bilgin, E Duran, E Ünaldı, U Kalyoncu, S Kiraz, İ Ertenli Rheumatology 61 (9), e267-e269, 2022 | 6 | 2022 |
| Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study group M Caminati, A Fassio, F Alberici, C Baldini, F Bello, P Cameli, E Conticini, ... Allergy 79 (2), 516-519, 2024 | 5 | 2024 |
| Vital corner of diagnostic challenge: eosinophilic granulomatosis with polyangiitis or COVID-19 pneumonia? E Duran, L Kilic, G Durhan, AÇ Inkaya, GS Guven, G Karakaya, ... Annals of the rheumatic diseases 82 (4), e85-e85, 2023 | 5 | 2023 |
| The frequency of Achilles and plantar calcaneal spurs in gout patients E Duran, E Bilgin, Aİ Ertenli, U Kalyoncu Turkish Journal of Medical Sciences 51 (4), 1841-1848, 2021 | 5 | 2021 |
| The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases? E Duran, OC Bostan, E Bilgin, SB Kaya, EC Bolek, S Ozer, E Damadoğlu, ... Internal and Emergency Medicine, 1-9, 2022 | 4 | 2022 |
| Ab0763 the Influence of obesity on biological DMARD treatment response in psoriatic arthritis: Hur-bio real life results B Farisoğullari, GK Yardimci, EC Bolek, E Bilgin, E Duran, G Ayan, L Kiliç, ... Annals of the Rheumatic Diseases 79 (Suppl 1), 1679-1680, 2020 | 3 | 2020 |
| Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry B Farisoğulları, GK Yardımcı, A Sarı, E Bilgin, EÇ Bölek, E Duran, L Kılıç, ... Clinical and experimental rheumatology 40, 112-119, 2022 | 2 | 2022 |
| COVID-19 enfeksiyonunda sitokin fırtınası ve potansiyel terapötik hedefler E DURAN, L KILIÇ Turkiye Klinikleri COVID-19 1 (40), 54-60, 2020 | 2 | 2020 |
| The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study B Yagiz, N Lermi, BN Coskun, E Dalkilic, S Kiraz, A Erden, I Ertenli, ... Rheumatology 62 (12), 3962-3967, 2023 | 1 | 2023 |
| AB0777 PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS) EC Bolek, G Ayan, E Bilgin, ED Ediboglu, E Duran, RC Kardaş, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1597-1598, 2023 | 1 | 2023 |
| Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study O Can Bostan, E Duran, G Tuncay, M Cihanbeylerden, O Karadag, ... Journal of Asthma 60 (5), 931-937, 2023 | 1 | 2023 |
| ANCA iliŞkili vaskülit değerlendirmesinde yeni oyuncu: Hasta kaynaklı ölçütler (AAV-PRO): Gerçek yaşam deneyimi. EE Levent, E Bilgin, E Sarıyıldız, EÇ Bölek, L Kılıç, Ö Karadağ Journal of Turkish Society for Rheumatology 14, 2022 | 1 | 2022 |
| AB0843 OSTEOPOROSIS IN PATIENTS WITH SPONDYLOARTHRITIS: DO WE NEED TO DO MORE? Z Özsoy, K Moral, F Yeşil, E Bilgin, EC Bolek, GK Yardimci, B Farisogullari, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1547-1547, 2022 | 1 | 2022 |
| AB0416 CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED≥ 60 YEARS E Duran, E Unaldi, E Bilgin, EC Bolek, GK Yardimci, B Farisogullari, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1336-1336, 2022 | 1 | 2022 |
